There have been 50 recent insider transactions recorded for Veracyte, Inc. (VCYT), including 7 buys and 42 sells. Total insider buying was valued at RSU Award and total insider selling at $11.45M.
Notable insiders with recent activity include Haas Kevin Richard, Stapley Marc, Wygant Jonathan. Insider transactions can provide insights into how company leadership views the stock's valuation and future prospects.
Insider Transactions — VCYT
| Date |
Name |
Role |
Transaction |
Shares |
Avg. Price |
Value |
Shares Owned |
| 2026-03-24 |
Haas Kevin Richard |
Officer |
Unknown |
- |
- |
- |
- |
| 2026-03-06 |
Stapley Marc |
Chief Executive Officer |
RSU Award |
92,099 |
- |
- |
449,653 |
| 2026-03-06 |
Wygant Jonathan |
VP, Chief Accounting Officer |
RSU Award |
10,525 |
- |
- |
45,434 |
| 2026-03-06 |
Febbo Phillip G. |
Chief Scientific & Med Officer |
RSU Award |
29,603 |
- |
- |
146,949 |
| 2026-03-06 |
Chambers Rebecca |
Chief Financial Officer |
RSU Award |
36,181 |
- |
- |
167,377 |
| 2026-03-06 |
Mcguire Annie |
SVP, General Counsel |
RSU Award |
32,892 |
- |
- |
127,598 |
| 2026-03-06 |
Leite John |
Chief Commercial Officer-clia |
RSU Award |
36,181 |
- |
- |
143,761 |
| 2026-03-04 |
Stapley Marc |
Chief Executive Officer |
Informative Sell |
26,279 |
$36.28 |
$953.37K |
357,554 |
| 2026-03-04 |
Chambers Rebecca |
Chief Financial Officer |
Informative Sell |
13,941 |
$36.33 |
$506.46K |
131,196 |
| 2026-03-04 |
Mcguire Annie |
SVP, General Counsel |
Informative Sell |
1,664 |
$36.34 |
$60.47K |
94,706 |
| 2026-03-04 |
Leite John |
Chief Commercial Officer-clia |
Informative Sell |
5,260 |
$35.19 |
$185.08K |
107,580 |
| 2026-03-02 |
Stapley Marc |
Chief Executive Officer |
Tax Withholding of RSU |
19,455 |
$36.01 |
$700.57K |
403,077 |
| 2026-03-02 |
Wygant Jonathan |
VP, Chief Accounting Officer |
Tax Withholding of RSU |
3,006 |
$36.01 |
$108.25K |
34,909 |
| 2026-03-02 |
Febbo Phillip G. |
Chief Scientific & Med Officer |
Informative Sell |
13,425 |
$36.16 |
$485.43K |
117,346 |
| 2026-03-02 |
Chambers Rebecca |
Chief Financial Officer |
Tax Withholding of RSU |
7,234 |
$36.01 |
$260.5K |
149,537 |
| 2026-03-02 |
Mcguire Annie |
SVP, General Counsel |
Tax Withholding of RSU |
6,902 |
$36.01 |
$248.54K |
101,364 |
| 2026-03-02 |
Leite John |
Chief Commercial Officer-clia |
Tax Withholding of RSU |
7,517 |
$36.01 |
$270.69K |
112,840 |
| 2026-02-26 |
Stapley Marc |
Chief Executive Officer |
Tax Withholding of RSU |
35,841 |
$38.75 |
$1.39M |
422,532 |
| 2026-02-26 |
Febbo Phillip G. |
Chief Scientific & Med Officer |
Tax Withholding of RSU |
24,486 |
$38.75 |
$948.83K |
136,806 |
| 2026-02-26 |
Chambers Rebecca |
Chief Financial Officer |
Tax Withholding of RSU |
12,049 |
$38.75 |
$466.9K |
156,771 |
| 2026-02-26 |
Mcguire Annie |
SVP, General Counsel |
Tax Withholding of RSU |
10,867 |
$38.75 |
$421.1K |
108,266 |
| 2026-02-26 |
Leite John |
Chief Commercial Officer-clia |
Tax Withholding of RSU |
8,905 |
$38.75 |
$345.07K |
120,357 |
| 2025-12-16 |
Mcguire Annie |
SVP, General Counsel |
Informative Sell |
100 |
$43.68 |
$4.37K |
67,760 |
| 2025-12-05 |
Eastham Karin |
Director |
Option Exercise (Sell) |
10,000 |
$7.94 |
$79.4K |
- |
| 2025-12-04 |
Stapley Marc |
Chief Executive Officer |
Informative Sell |
3,220 |
$47.35 |
$152.46K |
318,603 |
| 2025-12-04 |
Chambers Rebecca |
Chief Financial Officer |
Informative Sell |
4,741 |
$47.25 |
$224.01K |
109,496 |
| 2025-12-04 |
Mcguire Annie |
SVP, General Counsel |
Informative Sell |
702 |
$47.51 |
$33.35K |
78,499 |
| 2025-12-04 |
Leite John |
Chief Commercial Officer-clia |
Informative Sell |
1,278 |
$47.51 |
$60.72K |
82,113 |
| 2025-12-02 |
Stapley Marc |
Chief Executive Officer |
Tax Withholding of RSU |
7,914 |
$46.16 |
$365.31K |
326,271 |
| 2025-12-02 |
Wygant Jonathan |
VP, Chief Accounting Officer |
Tax Withholding of RSU |
1,325 |
$46.16 |
$61.16K |
37,420 |
| 2025-12-02 |
Febbo Phillip G. |
Chief Scientific & Med Officer |
Tax Withholding of RSU |
2,955 |
$46.16 |
$136.4K |
89,486 |
| 2025-12-02 |
Chambers Rebecca |
Chief Financial Officer |
Tax Withholding of RSU |
3,384 |
$46.16 |
$156.21K |
122,774 |
| 2025-12-02 |
Mcguire Annie |
SVP, General Counsel |
Tax Withholding of RSU |
3,052 |
$46.16 |
$140.88K |
79,921 |
| 2025-12-02 |
Leite John |
Chief Commercial Officer-clia |
Tax Withholding of RSU |
2,900 |
$46.16 |
$133.86K |
83,391 |
| 2025-11-25 |
Jones Evan/ Fa |
Director |
Informative Sell |
1,106 |
$50.25 |
$55.58K |
29,362 |
| 2025-11-25 |
Leite John |
Chief Commercial Officer-clia |
Informative Sell |
2,808 |
$50.00 |
$140.4K |
86,291 |
| 2025-11-20 |
Holstein Jens |
Director |
Informative Sell |
1,460 |
$43.21 |
$63.09K |
27,199 |
| 2025-11-10 |
Wygant Jonathan |
VP, Chief Accounting Officer |
Informative Sell |
5,102 |
$42.33 |
$215.98K |
38,745 |
| 2025-11-07 |
Wygant Jonathan |
VP, Chief Accounting Officer |
Informative Sell |
5,818 |
$40.21 |
$233.93K |
43,847 |
| 2025-11-05 |
Jones Evan/ Fa |
Director |
Option Exercise (Sell) |
10,000 |
$5.28 |
$52.8K |
- |
| 2025-11-05 |
Eastham Karin |
Director |
Informative Sell |
9,674 |
$40.02 |
$387.19K |
13,554 |
| 2025-11-05 |
Chambers Rebecca |
Chief Financial Officer |
Informative Sell |
7,000 |
$41.00 |
$287K |
126,158 |
| 2025-11-05 |
Mcguire Annie |
SVP, General Counsel |
Informative Sell |
6,466 |
$40.00 |
$258.64K |
82,973 |
| 2025-10-28 |
Wygant Jonathan |
VP, Chief Accounting Officer |
RSU Award |
2,886 |
- |
- |
49,665 |
| 2025-10-06 |
Febbo Phillip G. |
Chief Scientific & Med Officer |
Informative Sell |
8,349 |
$36.02 |
$300.71K |
92,441 |
| 2025-10-01 |
Epstein Robert S |
Director |
Option Exercise (Sell) |
10,000 |
$7.94 |
$79.4K |
- |
| 2025-10-01 |
Mcguire Annie |
SVP, General Counsel |
Informative Sell |
2,160 |
$35.00 |
$75.61K |
89,439 |
| 2025-10-01 |
Leite John |
Chief Commercial Officer-clia |
Informative Sell |
2,539 |
$35.00 |
$88.87K |
89,099 |
| 2025-09-19 |
Mcguire Annie |
SVP, General Counsel |
Informative Sell |
2,283 |
$33.69 |
$76.92K |
91,599 |
| 2025-09-04 |
Stapley Marc |
Chief Executive Officer |
Informative Sell |
7,667 |
$30.41 |
$233.13K |
334,185 |
■ Informative Buy/Sell — open market transaction (most significant)
■ Uninformative Buy — award, option exercise, conversion
■ Uninformative Sell — tax withholding, award vest sale
■ Neutral — gift, trust, expiry
